HERON THERAPEUTICS, INC. /DE/ Increase (Decrease) in Accrued Liabilities
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Increase (Decrease) in Accrued Liabilities of -$2.01 million for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2014-05-12
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in accrued liabilities for the quarter ending 2014-03-31 was -$2.01M, a 236.80% decline year-over-year.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in accrued liabilities for the quarter ending 2013-12-31 was $2.42M, a 206.46% increase year-over-year.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in accrued liabilities for the quarter ending 2013-09-30 was -$1.06M, a 3871.43% decline year-over-year.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in accrued liabilities for the quarter ending 2013-06-30 was $412.00K.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in accrued liabilities for fiscal 2013 was $3.24M, a 642.33% increase from fiscal 2012.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in accrued liabilities for fiscal 2012 was $437.00K, a 66.33% decline from fiscal 2011.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in accrued liabilities for fiscal 2011 was $1.30M.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in accrued liabilities for fiscal 2010 was -$579.00K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2014-03-31 | -$2.01M 10-Q · filed 2014-05-12 | $407.00K derived: sum of 2 quarters · filed 2014-05-12 | -$649.00K derived: sum of 3 quarters · filed 2014-05-12 | -$237.00K derived: sum of 4 quarters · filed 2014-05-12 |
| 2013-12-31 | $2.42M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $1.36M derived: sum of 2 quarters · filed 2014-03-07 | $1.77M derived: sum of 3 quarters · filed 2014-03-07 | $3.24M 10-K · filed 2014-03-07 |
| 2013-09-30 | -$1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$644.00K derived: sum of 2 quarters · filed 2013-11-12 | $826.00K 10-Q · filed 2013-11-12 | $1.61M derived: sum of 4 quarters · filed 2014-05-12 |
| 2013-06-30 | $412.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $1.88M 10-Q · filed 2013-08-08 | $2.67M derived: sum of 3 quarters · filed 2014-05-12 | $2.70M derived: sum of 4 quarters · filed 2014-05-12 |
| 2013-03-31 | $1.47M 10-Q · filed 2014-05-12 | $2.26M derived: sum of 2 quarters · filed 2014-05-12 | $2.29M derived: sum of 3 quarters · filed 2014-05-12 | $2.21M derived: sum of 4 quarters · filed 2014-05-12 |
| 2012-12-31 | $789.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $817.00K derived: sum of 2 quarters · filed 2014-03-07 | $741.00K derived: sum of 3 quarters · filed 2014-03-07 | $437.00K 10-K · filed 2014-03-07 |
| 2012-09-30 | $28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$48.00K derived: sum of 2 quarters · filed 2013-11-12 | -$352.00K 10-Q · filed 2013-11-12 | $236.00K derived: sum of 4 quarters · filed 2014-03-07 |
| 2012-06-30 | -$76.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$380.00K 10-Q · filed 2013-08-08 | $208.00K derived: sum of 3 quarters · filed 2014-03-07 | $627.00K derived: sum of 4 quarters · filed 2014-03-07 |
| 2012-03-31 | -$304.00K 10-Q · filed 2013-05-10 | $284.00K derived: sum of 2 quarters · filed 2014-03-07 | $703.00K derived: sum of 3 quarters · filed 2014-03-07 | $1.10M derived: sum of 4 quarters · filed 2014-03-07 |
| 2011-12-31 | $588.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $1.01M derived: sum of 2 quarters · filed 2014-03-07 | $1.40M derived: sum of 3 quarters · filed 2014-03-07 | $1.30M 10-K · filed 2014-03-07 |
| 2011-09-30 | $419.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | $813.00K derived: sum of 2 quarters · filed 2012-11-05 | $710.00K 10-Q · filed 2012-11-05 | $655.00K derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-06-30 | $394.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $291.00K 10-Q · filed 2012-08-09 | $236.00K derived: sum of 3 quarters · filed 2013-03-01 | -$1.09M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-03-31 | -$103.00K 10-Q · filed 2012-05-10 | -$158.00K derived: sum of 2 quarters · filed 2013-03-01 | -$1.49M derived: sum of 3 quarters · filed 2013-03-01 | |
| 2010-12-31 | -$55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | -$1.38M derived: sum of 2 quarters · filed 2013-03-01 | -$579.00K 10-K · filed 2013-03-01 | |
| 2010-09-30 | -$1.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | -$524.00K 10-Q · filed 2011-11-07 | ||
| 2010-06-30 | $805.00K 10-Q · filed 2011-08-08 | |||
| 2009-12-31 | -$1.16M 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |